Specifically, the MEK5/ERK5 pathway has emerged as apromising novel therapeutic target for breast cancer, as this signaling pathway regulatesprocesses integral to breast cancer, including initiation, progression, metastasis, and drugresistance. The gene discussed is MAPK7; the disease is breast cancer.